The GLP-1 receptor, a G protein-coupled receptor (GPCR) expressed in the gastrointestinal tract, the cardiovascular system, the hypothalamus, and pancreatic islet cells, is activated by semaglutide
Healthcare professionals typically recommend a combination of lifestyle modifications, monitoring strategies, and medication optimisation
This trend indicates a shift in consumer attitudes towards proactive health management, with GLP-1 drugs being recognized for their dual benefits of weight loss and glycemic control
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S
in early January 2026
Capacity, however, is nearly impossible to measure accurately